Jade Biosciences (NasdaqCM:JBIO) FY Conference March 02, 2026 10:30 AM ET Company ParticipantsAndrew King - Chief Scientific Officer and Head of Research and DevelopmentBrad Dahms - CFOConference Call ParticipantsTyler Van Buren - Managing Director and Senior Equity Research AnalystNone - AnalystTyler Van BurenThere we go. All right. Good morning, everyone. Welcome again to TD Cowen's 46th Annual Healthcare Conference. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen. For our next session, I'm very ...